These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

527 related articles for article (PubMed ID: 27707707)

  • 1. Insulin resistance in chronic kidney disease: a systematic review.
    Spoto B; Pisano A; Zoccali C
    Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1087-F1108. PubMed ID: 27707707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin resistance in chronic kidney disease.
    Xu H; Carrero JJ
    Nephrology (Carlton); 2017 Dec; 22 Suppl 4():31-34. PubMed ID: 29155496
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin resistance as a therapeutic target for chronic kidney disease.
    Teta D
    J Ren Nutr; 2015 Mar; 25(2):226-9. PubMed ID: 25511524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin D deficiency, insulin resistance, and ventricular hypertrophy in the early stages of chronic kidney disease.
    Lai S; Coppola B; Dimko M; Galani A; Innico G; Frassetti N; Mariotti A
    Ren Fail; 2014 Feb; 36(1):58-64. PubMed ID: 24028070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin resistance and chronic kidney disease progression, cardiovascular events, and death: findings from the chronic renal insufficiency cohort study.
    Schrauben SJ; Jepson C; Hsu JY; Wilson FP; Zhang X; Lash JP; Robinson BM; Townsend RR; Chen J; Fogelfeld L; Kao P; Landis JR; Rader DJ; Hamm LL; Anderson AH; Feldman HI
    BMC Nephrol; 2019 Feb; 20(1):60. PubMed ID: 30786864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor-23 is a strong predictor of insulin resistance among chronic kidney disease patients.
    Fayed A; El Nokeety MM; Heikal AA; Abdulazim DO; Naguib MM; Sharaf El Din UAA;
    Ren Fail; 2018 Nov; 40(1):226-230. PubMed ID: 29619868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic kidney disease and obesity bias surrogate estimates of insulin sensitivity compared with the hyperinsulinemic euglycemic clamp.
    Ahmad I; Zelnick LR; Robinson NR; Hung AM; Kestenbaum B; Utzschneider KM; Kahn SE; de Boer IH
    Am J Physiol Endocrinol Metab; 2017 Mar; 312(3):E175-E182. PubMed ID: 28073780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic Kidney Disease-Induced Insulin Resistance: Current State of the Field.
    Dave N; Wu J; Thomas S
    Curr Diab Rep; 2018 Jun; 18(7):44. PubMed ID: 29884917
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of insulin resistance in chronic kidney disease.
    Pham H; Utzschneider KM; de Boer IH
    Curr Opin Nephrol Hypertens; 2011 Nov; 20(6):640-6. PubMed ID: 21885970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabonomic Profiling Reveals Difference in Altered Metabolic Pathways Between Chronic Kidney Disease and High-Fat-Induced Insulin Resistance in Rats.
    Xu Z; Zhang L; Li J; Zhao Y; Chen X
    Kidney Blood Press Res; 2018; 43(4):1199-1211. PubMed ID: 30071523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic kidney disease attenuates the plasma metabolome response to insulin.
    Roshanravan B; Zelnick LR; Djucovic D; Gu H; Alvarez JA; Ziegler TR; Gamboa JL; Utzschneider K; Kestenbaum B; Himmelfarb J; Kahn SE; Raftery D; de Boer IH
    JCI Insight; 2018 Aug; 3(16):. PubMed ID: 30135309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin resistance in chronic kidney disease: new lessons from experimental models.
    Koppe L; Pelletier CC; Alix PM; Kalbacher E; Fouque D; Soulage CO; Guebre-Egziabher F
    Nephrol Dial Transplant; 2014 Sep; 29(9):1666-74. PubMed ID: 24286973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Insulin resistance as a predictor of cardiovascular morbidity and end-stage renal disease.
    Fragoso A; Mendes F; Silva AP; Neves PL
    J Diabetes Complications; 2015; 29(8):1098-104. PubMed ID: 26066409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of insulin sensitivity surrogate indices and prediction of clinical outcomes in individuals with and without impaired renal function.
    Jia T; Huang X; Qureshi AR; Xu H; Ärnlöv J; Lindholm B; Cederholm T; Stenvinkel P; Risérus U; Carrero JJ
    Kidney Int; 2014 Aug; 86(2):383-91. PubMed ID: 24476695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance and vascular dysfunction in chronic kidney disease: mechanisms and therapeutic interventions.
    Chan DT; Watts GF; Irish AB; Dogra GK
    Nephrol Dial Transplant; 2017 Aug; 32(8):1274-1281. PubMed ID: 26374599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin resistance is associated with Fibroblast Growth Factor-23 in stage 3-5 chronic kidney disease patients.
    Garland JS; Holden RM; Ross R; Adams MA; Nolan RL; Hopman WM; Morton AR
    J Diabetes Complications; 2014; 28(1):61-5. PubMed ID: 24125760
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors determining insulin resistance in chronic hemodialysis patients.
    Hung AM; Ikizler TA
    Contrib Nephrol; 2011; 171():127-134. PubMed ID: 21625101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin Resistance and Insulin Handling in Chronic Kidney Disease.
    Parvathareddy VP; Wu J; Thomas SS
    Compr Physiol; 2023 Sep; 13(4):5069-5076. PubMed ID: 37770191
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease.
    Chalmers L; Kaskel FJ; Bamgbola O
    Adv Chronic Kidney Dis; 2006 Oct; 13(4):352-64. PubMed ID: 17045221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating Alpha-Tocopherol and Insulin Sensitivity Among Older Men With Chronic Kidney Disease.
    Xu H; Xiong Z; Ärnlöv J; Qureshi AR; Cederholm T; Sjögren P; Lindholm B; Risérus U; Carrero JJ
    J Ren Nutr; 2016 May; 26(3):177-82. PubMed ID: 26776598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.